PerkinElmer this week said it has expanded its "no wash" Amplified Luminescent Proximity Homogeneous Assay, or ALPHA, technology portfolio, to include 28 new cell signaling pathway and biomarker research assay kits.
The new offerings include nine AlphaScreen SureFire immunoassay kits, which contain endogenous cellular kinase assays for research into the expression and function of particular phosphoproteins within cellular pathways.
Also new is the AlphaLisa immunoassay for the study of biomarkers, which offers "more options for human and mouse proteins," PerkinElmer said in a statement.
Aushon BioSystems this week launched its human multiplex biomarker panels for the quantification of seven biomarkers associated with drug-induced vascular injury.
The Human Vascular Injury Panels include E-selectin; P-selectin; ICAM-3: thrombomodulin; ICAM-1: VCAM-1; and SAA.
The panels, which were developed using Aushon's SearchLight protein array technology, are validated for analysis of serum, plasma, and tissue culture samples, the company said in a statement.
Premier Biosoft International this week launched SimGlycan version 2.90.
The updated program can analyze up to 500 peaks at a time, and users can create a search parameter template to apply all the peak list datasets and generate a comprehensive report of findings, the company said in a statement.